Issues and controversies in the treatment of HER2 positive metastatic breast cancer


Targeted therapies against the human epidermal growth factor receptor HER2, have led to revolutionary strides in breast cancer research and treatment. Clinical therapeutic decisions in the treatment of patients with HER2 positive metastatic breast cancer are based on appropriate patient selection, the clinical situation, and data related to the available… (More)
DOI: 10.1007/s10549-007-9636-2


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics